|
시장보고서
상품코드
1808846
세계의 분자 파밍 시장 : 제품 유형별, 식물 유형별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)Molecular Pharming Market, By Product Type, By Plant Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 |
||||||
분자 파밍 시장은 2024년에는 17억 8,724만 달러로 평가되어 2025-2032년에 걸쳐 CAGR 8.5%로 성장할 전망입니다.
분자 파밍 시장은 유전자 개질된 식물을 활용하여 백신, 항체, 효소, 치료제 등의 의약품 물질을 생산하는 것을 의미합니다. 이 혁신적인 생물공정(bioEnd-user process)은 원하는 치료제 단백질을 암호화하는 특정 유전자를 삽입하여 식물을 생물공장(biofactories)으로 변환합니다. 분자 파밍은 기존 세포 기반 또는 미생물 발효 방식에 비해 비용 효율적이고 확장 가능하며 안전한 대안을 제공합니다. 이는 인간 병원체로부터의 오염 위험을 제거하며 보건 위기 시 신속하게 전개될 수 있습니다.
담배, 옥수수, 쌀과 같은 작물은 빠른 성장 속도와 유전자 조작 용이성으로 인해 흔히 사용됩니다. 이 기술은 특히 자원이 부족한 환경에서 백신 생산에 혁명을 일으킬 잠재력으로 주목받고 있습니다. 안전성과 효능에 대한 우려를 해결하기 위한 규제 체계가 진화하면서 시장 도입이 가속화되고 있습니다. 특히 감염병, 암, 희귀 질환을 대상으로 한 바이오기술 연구개발(R&D) 투자 증가와 함께 수요가 상승하고 있습니다.
분자 파밍 시장 - 시장 역학
자원이 부족한 환경 및 팬데믹 상황에서 식물 기반 백신에 대한 수요 증가
분자 파밍 시장의 주요 틈새 성장 촉진 요인은 특히 저자원 환경 및 팬데믹 상황에서 식물 기반 백신에 대한 수요 증가입니다. 기존 백신 생산 방식은 고가의 인프라, 콜드체인, 긴 제조 기간에 의존하는 경우가 많아 개발도상국에서는 접근성이 떨어집니다. 분자 파밍은 최소한의 자원으로 현지에서 재배 가능한 식물을 활용해 신속하고 확장 가능하며 비용 효율적인 생산을 가능케 함으로써 해결책을 제시합니다.
이 접근법은 속도와 확장성이 중요한 전 세계 보건 비상사태 시 특히 가치가 높습니다. 식물 기반 시스템은 동물 또는 인간 병원체 오염 위험을 감축합니다. 또한 유전자 공학의 발전으로 식물 기반 백신 개발의 정밀성과 효율성이 향상되었습니다. 경구 또는 식용 백신 생산 능력은 배포가 용이한 새로운 전달 방법을 열어줍니다. 이러한 증가하는 관심은 분자 파밍을 공평한 전 세계 의료를 위한 전략적 공구로 뒷받침합니다.
분자 파밍 시장 - 세분화 분석
세계의 분자 파밍 시장은 제품 유형, 식물 유형, 용도, 최종 사용자 및 지역에 따라 세분화됩니다.
제품 유형에 따라 시장은 백신, 단일클론항체, 치료용 단백질, 효소 및 진단용 단백질의 세 가지 범주로 나뉩니다. 제품 유형별 분자 농업 시장에서 가장 지배적인 부문은 백신입니다. 분자 농업으로 생산된 백신은 기존 방식 대비 신속하고 대규모이며 비용 효율적인 생산 가능성으로 인해 상당한 주목을 받고 있습니다. 식물 기반 백신은 더 빠르게 개발될 수 있으며, 이는 시간이 중요한 발병 및 팬데믹 상황에서 매우 중요합니다. 또한 식물은 인간 병원체를 보유하지 않아 오염 위험을 감축하므로, 분자 농업은 더 안전한 백신 생산을 가능하게 합니다.
이 부문은 특히 기존 백신 제조 인프라가 제한적인 개발도상국을 중심으로 저렴한 백신에 대한 전 세계 수요 증가의 혜택을 받고 있습니다. 유전자 공학의 발전으로 식물 시스템 내 백신 효능과 안정성이 향상되었습니다. 인플루엔자, 코로나19 및 기타 바이러스 감염과 같은 감염병에 주력하면서 이 부문의 성장을 더욱 촉진하고 있습니다. 또한 규제 기관들은 점차 식물 유래 백신에 대한 명확한 프레임워크를 마련하며 시장 확장을 뒷받침하고 있습니다. 전반적으로 백신은 분자 파밍 시장의 성장과 혁신을 주도하는 주요 제품 유형으로 남아 있습니다.
시장은 식물 유형에 따라 담배, 옥수수, 쌀, 감자, 조류 및 기타 등 네 가지 범주로 구분됩니다. 식물 유형별 분자 파밍 시장에서 담배 부문이 가장 우세합니다. 담배 식물은 빠른 생장 속도, 높은 바이오매스 수율, 확립된 유전자 변형 기술로 선호됩니다. 식량 작물과 달리 담배는 인간 소비용으로 사용되지 않아 식품 공급망에서 교차 오염 우려를 최소화합니다. 담배 잎은 백신 및 단일클론 항체를 포함한 대량의 의약품 단백질 생산에 이상적인 플랫폼을 제공합니다.
또한 담배는 온실과 같은 통제된 환경에서 재배 가능하여 일관되고 확장 가능한 생산이 가능합니다. 많은 선도적 바이오테크 기업들은 감염병 항체 생산을 포함한 보건 비상사태 시 신속 대응을 위해 담배 식물을 활용해 왔습니다. 담배를 숙주 식물로 활용한 광범위한 연구와 인프라가 다른 식물 유형 대비 경쟁 우위를 제공합니다. 결과적으로 담배는 분자 파밍 식물 유형으로 선호되는 선택지로서 상당한 시장 성장을 촉진하고 있습니다.
분자 파밍 시장 - 지리적 인사이트
북미는 고급 인프라, 상당한 연구개발(R&D) 투자, 지원적인 규제 환경을 바탕으로 전 세계 분자 파밍 시장을 주도하고 있습니다. 특히 미국은 식물 기반 의약품 생산을 선도하는 수많은 바이오테크 기업과 연구 기관을 보유하고 있습니다. 이 지역은 강력한 의료 시스템, 높은 의료 지출, 유리한 환급 정책의 혜택을 받아 혁신적인 치료법 도입이 용이합니다. 업계 리더, 학술 기관, 정부 기관 간의 협력은 분자 파밍 기술 개발을 가속화했습니다.
분자 파밍 시장 - 경쟁 구도
분자 파밍 시장은 Kentucky Bioprocessing, Medicago, iBio, Ventria Bioscience, Protalix BioTherapeutics 등 주요 기업이 경쟁 구도를 지배하고 있습니다. 이들 업체는 식물 내 단백질 발현 및 생산 효율성 향상을 위한 혁신을 주력하고 있습니다. 학계 및 정부 기관과의 전략적 파트너십은 흔히 이루어지며, 이는 연구 개발 및 규제 승인을 가속화하는 데 도움이 됩니다. 지적 재산권 보호는 중요한 요인으로, 많은 업체들이 경쟁 엣지를 유지하기 위해 특허를 확보하고 있습니다.
일관된 품질과 확장성을 보장하기 위해 제어 환경 농업 및 바이오리액터를 포함한 고급 재배 기술에 대한 투자가 증가하고 있습니다. 또한 업체들은 백신 및 단일클론 항체와 같은 특정 치료제 분야를 목표로 삼아 차별화를 꾀하고 있습니다. 복잡한 규제 체계를 탐색하는 것은 여전히 도전 과제이자 진입 장벽으로 작용하여 기존 업체들이 입지를 강화할 수 있게 합니다. 전반적으로 경쟁은 기술 발전을 촉진하고 분자 농업 솔루션의 광범위한 채택을 이끌고 있습니다.
목차
제1장 분자 파밍 시장 개요
- 조사 범위
- 시장 추정 연도
제2장 주요 요약
- 시장 분석
- 경쟁 인사이트
제3장 분자 파밍의 주요 시장 동향
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 시장 전망 동향
제4장 분자 파밍 산업 연구
- PEST 분석
- Porter's Five Forces 분석
- 성장 전망 맵핑
- 규제 틀 분석
제5장 분자 파밍 시장 : 높아지는 지정학적 긴장 영향
- COVID-19 팬데믹 영향
- 러시아·우크라이나 전쟁 영향
- 중동 분쟁 영향
제6장 분자 파밍 시장의 정세
- 분자 파밍 시장 점유율 분석(2024년)
- 주요 제조업체별 분석 데이터
- 기존 기업 분석
- 신흥기업 분석
제7장 분자 파밍 시장 : 제품 유형별
- 개요
- 제품 유형별 부문 점유율 분석
- 백신
- 단일클론항체
- 치료용 단백질
- 효소
- 진단용 단백질
제8장 분자 파밍 시장 : 식물 유형별
- 개요
- 식물 유형별 부문 점유율 분석
- 담배
- 옥수수
- 쌀
- 감자
- 조류
- 기타
제9장 분자 파밍 시장 : 용도별
- 개요
- 용도별 부문 점유율 분석
- 감염증
- 암
- 희소질환
- 자가면역질환
- 기타
제10장 분자 파밍 시장 : 최종 사용자별
- 개요
- 최종 사용자별 부문 점유율 분석
- 제약회사
- 생명공학 기업
- 연구기관
- 계약연구기관(CRO)
제11장 분자 파밍 시장 : 지역별
- 소개
- 북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
- 유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
- 아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
- 라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
- 중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타
제12장 주요 벤더 분석 - 분자 파밍업계
- 경쟁 대시보드
- Competitive Benchmarking
- Competitive Positioning
- 기업 프로파일
- Kentucky Bioprocessing
- Medicago
- iBio
- Ventria Bioscience
- Protalix BioTherapeutics
- PlantForm Corporation
- Caliber Biotherapeutics
- Fraunhofer USA
- Icon Genetics
- Greenovation Biotech
- Dow AgroSciences
- Zymeworks
- Bayer CropScience
- Cibus
- PlantVax Inc.
- AquaBounty Technologies
- Phyton Biotech
- Vaxess Technologies
- Medicago Inc.
- PlantForm Corp
제13장 애널리스트의 전방위적 전망
HBR 25.09.29Molecular Pharming Market size was valued at US$ 1,787.24 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.
The Molecular Pharming Market involves the use of genetically modified plants to produce pharmaceutical substances such as vaccines, antibodies, enzymes, and therapeutic proteins. This innovative bioEnd-user process transforms plants into biofactories by inserting specific genes that encode the desired therapeutic proteins. Molecular pharming offers a cost-effective, scalable, and safer alternative to traditional cell-based or microbial fermentation methods. It eliminates the risk of contamination from human pathogens and can be rapidly deployed during health crises.
Crops like tobacco, maize, and rice are commonly used due to their fast growth and ease of genetic manipulation. The End-user has gained attention for its potential to revolutionize vaccine production, especially in low-resource settings. Regulatory frameworks are evolving to address safety and efficacy concerns, helping accelerate market adoption. Demand is rising with increased investment in biotech R&D, especially for infectious diseases, cancer, and rare disorders.
Molecular Pharming Market- Market Dynamics
Rising demand for plant-based vaccines in low-resource and pandemic scenarios.
A key niche driver for the molecular pharming market is the rising demand for plant-based vaccines, especially in low-resource settings and during pandemic scenarios. Traditional vaccine production methods often rely on expensive infrastructure, cold chains, and long manufacturing timelines, making them less accessible in developing regions. Molecular pharming offers a solution by enabling rapid, scalable, and cost-effective production using plants, which can be grown locally with minimal resources.
This approach is particularly valuable during global health emergencies when speed and scalability are critical. Plant-based systems also reduce the risk of contamination with animal or human pathogens. Furthermore, advances in genetic engineering have enhanced the precision and efficiency of plant-based vaccine development. The ability to produce oral or edible vaccines also opens up new delivery methods that are easier to distribute. This growing interest supports molecular pharming as a strategic tool for equitable global healthcare.
Molecular Pharming Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)
Based on product type segmentation, vaccines were predicted to show maximum market share in the year 2024
Based on Plant Type segmentation, tobacco was the leading Plant Type in 2024
Based on Application segmentation, Infectious Diseases were the leading Application in 2024
Based on End-User segmentation, Pharmaceutical Companies were the leading Application in 2024
Based on region, North America was the leading revenue generator in 2024
Molecular Pharming Market- Segmentation Analysis:
The Global Molecular Pharming Market is segmented on the basis of Product Type, Plant Type, Application, End-user, and Region.
The market is divided into three categories based on product type: Vaccines, Monoclonal Antibodies, Therapeutic Proteins, Enzymes, and Diagnostic Proteins. The most dominant segment in the molecular pharming market by product type is vaccines. Vaccines produced through molecular pharming have gained significant traction due to their potential for rapid, large-scale, and cost-effective production compared to traditional methods. Plant-based vaccines can be developed faster, which is crucial during outbreaks and pandemics where time is critical. Additionally, molecular pharming allows for the production of safer vaccines, as plants do not carry human pathogens, reducing contamination risks.
This segment benefits from growing global demand for affordable vaccines, especially in developing countries where traditional vaccine manufacturing infrastructure is limited. Advances in genetic engineering have improved vaccine efficacy and stability in plant systems. The increasing focus on infectious diseases, such as influenza, COVID-19, and other viral infections, further drives growth in this segment. Furthermore, regulatory agencies are gradually developing clearer frameworks for plant-derived vaccines, supporting market expansion. Overall, vaccines remain the leading product type, fueling the growth and innovation within the molecular pharming market.
The market is divided into four categories based on Plant Type: Tobacco, Maize (Corn), Rice, Potato, Algae, and Others. The tobacco segment is the most dominant in the molecular pharming market by plant type. Tobacco plants are preferred due to their fast growth rate, high biomass yield, and well-established genetic modification techniques. Unlike food crops, tobacco is not used for human consumption, which minimizes concerns about cross-contamination in the food supply chain. Its leaves provide an ideal platform for producing large quantities of pharmaceutical proteins, including vaccines and monoclonal antibodies.
Additionally, tobacco's ability to be grown in controlled environments such as greenhouses allows for consistent and scalable production. Many leading biotech companies have leveraged tobacco plants for rapid response during health emergencies, including producing antibodies for infectious diseases. The extensive research and infrastructure around tobacco as a host plant give it a competitive advantage over other plant types. As a result, tobacco continues to be the preferred choice for molecular pharming Plant Types, driving significant market growth.
Molecular Pharming Market- Geographical Insights
North America leads the global molecular pharming market, driven by its advanced infrastructure, substantial R&D investments, and a supportive regulatory environment. The United States, in particular, hosts numerous biotech firms and research institutions that are pioneering plant-based pharmaceutical production. This region benefits from a robust healthcare system, high healthcare expenditures, and favorable reimbursement policies, facilitating the adoption of innovative therapies. Collaborations between industry leaders, academic institutions, and government agencies have accelerated the development of molecular pharming technologies.
The United States stands at the forefront of the molecular pharming market, driven by a confluence of robust infrastructure, substantial R&D investments, and a supportive regulatory environment. The nation's advanced bioEnd-user sector is characterized by cutting-edge research institutions, well-established laboratories, and a comprehensive supply chain network, facilitating the efficient development and Application of molecular pharming products. Government initiatives play a pivotal role, offering financial incentives and fostering collaborations between industry, academia, and research institutions, thereby accelerating innovation and commercialization.
Molecular Pharming Market- Competitive Landscape:
The molecular pharming market features a competitive landscape dominated by key players such as Kentucky Bioprocessing, Medicago, iBio, Ventria Bioscience, and Protalix BioTherapeutics. These companies focus heavily on innovation to improve protein expression and production efficiency in plants. Strategic partnerships with academic institutions and government bodies are common, helping to accelerate R&D and regulatory approvals. Intellectual property protection is a critical factor, with many players securing patents to maintain their competitive edge.
Investments in advanced cultivation technologies, including controlled environment agriculture and bioreactors, are increasing to ensure consistent quality and scalability. Additionally, companies differentiate themselves by targeting specific therapeutic areas like vaccines and monoclonal antibodies. Navigating complex regulatory frameworks remains a challenge but also a barrier to entry, allowing established players to strengthen their positions. Overall, the competition drives technological progress and wider adoption of molecular pharming solutions.
Recent Developments:
In October 2024, Moolec Science obtained U.S. regulatory approval for genetically engineered peas (PEEA1) that produce iron-rich bovine myoglobin, offering a plant-based source of iron for consumers.
In February 2024, New Zealand-based food tech startup Miruku raised $5 million in a pre-Series A financing round to expand its molecular farming platform aimed at producing dairy proteins and fats.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR PHARMING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Kentucky Bioprocessing
- Medicago
- iBio
- Ventria Bioscience
- Protalix BioTherapeutics
- PlantForm Corporation
- Caliber Biotherapeutics
- Fraunhofer USA
- Icon Genetics
- Greenovation Biotech
- Dow AgroSciences
- Zymeworks
- Bayer CropScience
- Cibus
- PlantVax Inc.
- AquaBounty Technologies
- Phyton Biotech
- Vaxess Technologies
- Medicago Inc.
- PlantForm Corp.
GLOBAL MOLECULAR PHARMING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Vaccines
- Monoclonal Antibodies
- Therapeutic Proteins
- Enzymes
- Diagnostic Proteins
GLOBAL MOLECULAR PHARMING MARKET, BY PLANT TYPE- MARKET ANALYSIS, 2019 - 2032
- Tobacco
- Maize (Corn)
- Rice
- Potato
- Algae
- Others
GLOBAL MOLECULAR PHARMING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Infectious Diseases
- Cancer
- Rare Diseases
- Autoimmune Disorders
- Others
GLOBAL MOLECULAR PHARMING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Contract Research Organizations (CROs)
GLOBAL MOLECULAR PHARMING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Molecular Pharming Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Molecular Pharming Market Snippet by Product Type
- 2.1.2. Molecular Pharming Market Snippet by Plant Type
- 2.1.3. Molecular Pharming Market Snippet by Application
- 2.1.4. Molecular Pharming Market Snippet by End-user
- 2.1.5. Molecular Pharming Market Snippet by Country
- 2.1.6. Molecular Pharming Market Snippet by Region
- 2.2. Competitive Insights
3. Molecular Pharming Key Market Trends
- 3.1. Molecular Pharming Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Molecular Pharming Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Molecular Pharming Market Opportunities
- 3.4. Molecular Pharming Market Future Trends
4. Molecular Pharming Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Molecular Pharming Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Molecular Pharming Market Landscape
- 6.1. Molecular Pharming Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Molecular Pharming Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Vaccines
- 7.1.3. Monoclonal Antibodies
- 7.1.4. Therapeutic Proteins
- 7.1.5. Enzymes
- 7.1.6. Diagnostic Proteins
8. Molecular Pharming Market - By Plant Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Plant Type, 2024 & 2032 (%)
- 8.1.2. Tobacco
- 8.1.3. Maize (Corn)
- 8.1.4. Rice
- 8.1.5. Potato
- 8.1.6. Algae
- 8.1.7. Others
9. Molecular Pharming Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Infectious Diseases
- 9.1.3. Cancer
- 9.1.4. Rare Diseases
- 9.1.5. Autoimmune Disorders
- 9.1.6. Others
10. Molecular Pharming Market - By End-user
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
- 10.1.2. Pharmaceutical Companies
- 10.1.3. Biotechnology Companies
- 10.1.4. Research Institutes
- 10.1.5. Contract Research Organizations (CROs)
11. Molecular Pharming Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Molecular Pharming Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Molecular Pharming Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Molecular Pharming Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Molecular Pharming Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Molecular Pharming Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Molecular Pharming Industry
- 12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Kentucky Bioprocessing
- 12.2.2. Medicago
- 12.2.3. iBio
- 12.2.4. Ventria Bioscience
- 12.2.5. Protalix BioTherapeutics
- 12.2.6. PlantForm Corporation
- 12.2.7. Caliber Biotherapeutics
- 12.2.8. Fraunhofer USA
- 12.2.9. Icon Genetics
- 12.2.10. Greenovation Biotech
- 12.2.11. Dow AgroSciences
- 12.2.12. Zymeworks
- 12.2.13. Bayer CropScience
- 12.2.14. Cibus
- 12.2.15. PlantVax Inc.
- 12.2.16. AquaBounty Technologies
- 12.2.17. Phyton Biotech
- 12.2.18. Vaxess Technologies
- 12.2.19. Medicago Inc.
- 12.2.20. PlantForm Corp
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
